RU92006182A -
ATTENUATED COLD-ADAPTED INFLUENZA VIRUS A / LENINGRAD / 134/17/57 / H2N2 / STRAIN FOR OBTAINING LIVE INTRANASAL GRIPOPOUS VACCINE STRAINS
- Google Patents
ATTENUATED COLD-ADAPTED INFLUENZA VIRUS A / LENINGRAD / 134/17/57 / H2N2 / STRAIN FOR OBTAINING LIVE INTRANASAL GRIPOPOUS VACCINE STRAINS
Info
Publication number
RU92006182A
RU92006182ARU92006182/13ARU92006182ARU92006182ARU 92006182 ARU92006182 ARU 92006182ARU 92006182/13 ARU92006182/13 ARU 92006182/13ARU 92006182 ARU92006182 ARU 92006182ARU 92006182 ARU92006182 ARU 92006182A
Использование: в медицинской вирусологии и для производства живой гриппозной вакцины и получения производственных штаммов живой гриппозной вакцины для профилактики гриппа у детей и взрослых. Сущность: вакцинный штамм А/Ленинград/134/17/57(H2N2) получен путем проведения 17 пассажей вируса А/Ленинград/134/57 в развивающихся куриных эмбрионах при температуре 25°С, что придало ему ts- и ха-маркеры, сохранив способность к стимуляции иммунитета. Аттенуированный холодоадаптированный штамм вируса гриппа А/Ленинград/134/17/57(H2N2) обладает гемагглютинирующей активностью 1:256 - 1: 280, инфекционной активностью 8,0 lg ЭИД 50/0,2 мл куриных эмбриональных доз. Штамм ареактогенен и иммуногенен для взрослых и детей.Usage: in medical virology and for the production of live influenza vaccine and the production of live strains of influenza vaccine for the prevention of influenza in children and adults. Essence: the vaccine strain A / Leningrad / 134/17/57 (H2N2) was obtained by conducting 17 passages of the A / Leningrad virus / 134/57 in developing chicken embryos at a temperature of 25 ° С, which gave it ts and ha-markers, retaining ability to stimulate immunity. Attenuated cold-adapted strain of influenza A / Leningrad / 134/17/57 (H2N2) has a hemagglutinating activity of 1: 256-1: 280, infectious activity of 8.0 lg EID 50 / 0.2 ml of chicken embryonic doses. Strain areactogenic and immunogenic for adults and children.
RU92006182/13A1992-11-16
ATTENUATED COLD-ADAPTED INFLUENZA VIRUS A / LENINGRAD / 134/17/57 / H2N2 / STRAIN FOR OBTAINING LIVE INTRANASAL GRIPOPOUS VACCINE STRAINS
RU92006182A
(en)
Vaccine against diseases caused by reo viruses, combined vaccine with newcastle disease virus, process for preparing them and reo virus strain used for their preparation
ATTENUATED COLD-ADAPTED REASSORTANT STRAIN OF THE INFLUENZA VIRUS A / 47 / LEKIN / 353/89/5 / NZN2 / FOR THE PRODUCTION OF LIVE INTRANASAL GRIPOPOUS VACCINE FOR CHILDREN
Molecular-genetic analysis of the cold-adapted strain, a donor of attenuation for live influenza vaccine for children, of the recombinants produced on its basis, and of isolates from vaccinated children.